First Molecular Test in US to Better Detect Brain Tumors Now Available to Patients

NYU Langone Health and its Perlmutter Cancer Center have launched clinical whole genome DNA methylation profiling for patients with brain tumors.
This leading-edge molecular assay utilizes DNA epigenetic signatures and artificial intelligence with machine learning to correctly identify and subtype brain tumors. NYU Langone Health is the first Clinical Laboratory Improvement Amendments (CLIA)-certified laboratory in the United States to receive state approval (New York State Department of Health) for whole genome DNA methylation for diagnosis and classification of brain tumors.

Read more

UK Partners With Bourbon Industry Leaders to Map White Oak Genome

Bourbon isn’t bourbon without the mighty white oak. Distillers have been aging bourbon in oak barrels as far back as the Roman Empire. Oak barrels give bourbon its unique caramel, vanilla, nutty and toasted flavors. Kentucky distillers rely especially on the white oak. But what if disease hits the species? How would industry professionals protect it? The University of Kentucky College of Agriculture, Food and Environment is partnering with Maker’s Mark Distillery Inc. in Loretto, Kentucky, and Independent Stave Company to research the DNA of the white oak.

Read more

Moderate to Heavy Drinking During Pregnancy Alters Genes in Newborns, Mothers

Mothers who drink moderate to high levels of alcohol during pregnancy may be changing their babies’ DNA, according to a Rutgers-led study.

Read more

Research into RNA-DNA ‘R-loops’ could shed light on cancer formation

Accumulation of unusual RNA-DNA hybrids, known as R-loops, are often associated with cancers. Xiaoyu Xue, assistant professor in the Department of Chemistry and Biochemistry at Texas State University, is heading a research study examining the role of the human motor protein Aquarius (AQR) in resolving R-loops to gain insight into possible avenues of cancer prevention.

Read more